FDA List Notes Drug Shortages Related to Intubation, Anxiety and Depression

In the early days of the COVID-19 pandemic, most drug companies issued statements assuring the public and investors that they were making efforts to secure their supply chains in order to ensure supplies of essential medications. Nonetheless, a USA Today report found that from January through May, 28 generic drugs in 405 dosages made the U.S. Food and Drug Administration (FDA)’s list of drugs in shortage.